Sexual Health
As-needed injectable
Acts on desire, not just blood flow
Works through melanocortin receptors in the brain to address desire itself, for patients whose concern is libido rather than mechanics.
Prescription treatment. Prescribed only when clinically appropriate, after review by a licensed provider.
What to expect
Targets desire rather than blood flow
Effective for both men and women
Works independently of the vascular pathway
Can be combined with PDE5 therapy under supervision
How it works
Bremelanotide activates melanocortin receptors in the central nervous system involved in sexual arousal. Because it is a neurological rather than vascular mechanism, it can help where PDE5 inhibitors alone do not.
Individual results vary.
Dosing
Injected subcutaneously roughly forty-five minutes before activity. Frequency is limited, and your provider will specify the maximum.
Safety information
Possible side effects
Not suitable for
Prescription treatment. Prescribed only when clinically appropriate, after review by a licensed provider. This is not a complete list of risks. Your provider will review your full medical history before prescribing.
Questions
Yes. Bremelanotide is FDA-approved for hypoactive sexual desire disorder in premenopausal women, and it is prescribed for men off-label.
Starting at a lower dose usually helps considerably. Your provider can also advise on timing and anti-nausea options.
Related treatments
Ready when you are
A licensed provider reviews your intake and prescribes pt-141 / bremelanotide only when clinically appropriate. Individual results vary.
Start your online visitPrescription treatment. Prescribed only when clinically appropriate, after review by a licensed provider.
